1. INTRODUCTION:

The global shift towards wellness and anti-aging has positioned the cosmeceutical sector—products blending cosmetics and pharmaceuticals—as a major growth driver. This detailed report serves as an exhaustive guide to the regulatory and operational intricacies governing this industry, with a focus on compliance within India's strict framework, defined primarily by the Drug and Cosmetics Act of 1940 and its subsequent rules^4,31. We thoroughly examine the foundational elements necessary for legal operation, including the complex licensing requirements, the critical role of documentation (Master Formula Records, Batch Formula Records), and the stringent quality standards mandated by Current Good Manufacturing Practices (CGMP) and ICH stability guidelines. Furthermore, the report investigates the specialized knowledge required for product development, covering biological anatomy, hygiene needs, and the necessary adjustments for ethnic formulation considerations. Finally, it outlines the critical role of modern manufacturing and Quality Control (QC) instrumentation, providing minor details on their operation to ensure product safety and efficacy ^5,16.

1.1 Introduction to the Cosmetics and Cosmeceuticals Industry:

a] Definition:

The terms 'cosmetic' and 'cosmeceutical' occupy a continuum in personal care. According to the Drug and Cosmetics Act, 1940 (D&C Act), a cosmetic is any article intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body or any part thereof for cleansing, beautifying, promoting attractiveness, or altering the appearance^4,31.

A cosmeceutical, while not a legally defined term under the D&C Act, is generally understood to be a cosmetic product that contains bioactive ingredients purported to have drug-like benefits. These products aim to improve skin function (e.g., reduce wrinkles, treat acne) but are regulated as cosmetics, provided their primary function remains "altering the appearance" rather than "treating or curing" a disease. This nuanced distinction places immense pressure on precise formulation and claims substantiation^1,22.

b] Industry Overview and Growth Drivers:

The Indian cosmeceutical market is characterized by rapid expansion, driven by increasing consumer awareness, disposable incomes, and the demand for science-backed personal care^1,5. Key growth factors include:

· Digital Commerce: E-commerce platforms facilitate wider distribution and consumer education on complex ingredients²¹.

· Focus on 'Free-From' Formulations: Demand for products free from parabens, sulfates, and specific chemicals mandates sophisticated manufacturing adjustments^5,22.

· Preventative Health: Cosmeceuticals are increasingly viewed as preventative healthcare, particularly in the anti-pollution and UV protection segments^17,41.

2. The Regulatory Authorities in India:

The manufacture, import, distribution, and sale of cosmetics and cosmeceuticals in India are primarily governed by the Drug and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. This comprehensive legislation ensures that the products sold to the public are safe, effective, and correctly labeled^13,31,42.

2.1 Overview of the Drugs and Cosmetics Act, 1940, and Rules, 1945:

a] Historical Context and Central Objective:

The Act was established to regulate the import, manufacture, distribution, and sale of drugs and cosmetics^4,31. Its central objective is consumer protection, ensuring that all products meet mandatory standards of quality, purity, and strength. For cosmetics, the focus is heavily on safety and preventing false or misleading claims¹³.

b] Regulatory Bodies:

1. Central Drugs Standard Control Organization (CDSCO): The principal regulatory body, responsible for:

· Approving new cosmetic ingredients or finished products for import.

· Setting standards (schedules and specifications) for quality.

· Granting Central Licenses (e.g., for imported cosmetics)⁴.

2. State Licensing Authorities (SLA): Responsible for

· Granting licenses for the manufacture, sale, and storage of cosmetics within their respective states.

· Conducting inspections of manufacturing and sales premises^4,7,43.

2.2. Classification and Definition of Cosmetics under the Act:

Section 3(a) of the D&C Act defines a cosmetic as "any article intended to be rubbed, poured, sprinkled, or sprayed on, or introduced into, or otherwise applied to, the human body or any part thereof for cleansing, beautifying, promoting attractiveness, or altering the appearance, and includes any article intended for use as a component of any such article."^31,43

a] Subtle Distinctions and Schedule K:

A key differentiation point lies in the claims made. If a product claims to "treat" or "cure" a condition (e.g., "cures psoriasis"), it is treated as a drug. If it claims to "moisturize," "reduce the appearance of wrinkles," or "cleanse," it remains a cosmetic. The formulation of cosmeceuticals often skirts this line, necessitating cautious and legally compliant marketing language.^17,22

2.3. Prohibitions on Import, Manufacture, and Sale:

The Act strictly prohibits several categories of cosmetics to safeguard public health. Any breach of these prohibitions leads to immediate legal action⁴.

a] Prohibited Imports (Section 10):

1. Substandard Cosmetics (Section 10(a))

2. Adulterated Cosmetics (Section 10(b))

3. Misbranded Cosmetics (Section 10(c))

4. Prohibited Ingredients (Section 10(d))

b] Prohibited Manufacture and Sale (Section 18):

1. Products without Valid License (Section 18(a))

2. Adulterated/ Misbranded/ Substandard Products (Section 18(b) and (c))

3. Patent or Proprietary Cosmetics

4. Use of Prohibited Dyes and Pigments

2.4. Offenses and Penalties:

The penalties for non-compliance are severe and depend on the nature and gravity of the offense. The legislation provides for both fines and imprisonment.

a] Penalties for Import and Manufacture (Sections 27 and 28):

Substandard/ Misbranded/ Spurious:

Manufacturing or selling cosmetics in contravention of the Act (like being substandard or misbranded) is punishable with imprisonment for a term that may extend to three years, or with a fine, or both.

Grave Offences:

(Adulterated/Spurious Products that Cause Injury): If the adulteration or manufacturing/selling of spurious cosmetics is likely to cause grievous hurt or death, the penalty can escalate significantly, potentially leading to life imprisonment^4,31

3. Licensing and Documentation Framework:

Successfully navigating the cosmeceutical industry requires obtaining the necessary legal permissions and maintaining an impeccable documentation system that tracks a product from raw material sourcing to final sale ^14,21.

3.1. Conditions for Obtaining a License for Import, Manufacture, Storage, and Sale:

The type of license required depends on the business activity (import, manufacture, or sale/storage) and the location^10,24.

a] Conditions for Manufacturing License (License No. 32):

This is the most complex license, typically issued by the State Licensing Authority (SLA) under Rule 138, after satisfying the conditions in Rules 139 and 140.

· Key Conditions:

· Premises Requirements: The manufacturing premises must comply with the conditions specified in Schedule M-II (for cosmetics CGMP). This includes:

1. Adequate space for manufacturing, testing, storage, and administrative areas.

2. Separation of manufacturing, testing, and quarantine areas to prevent cross-contamination.

3. Floors and walls must be smooth, washable, and free from cracks^10,24.

· Personnel Qualification:

a) Competent Technical Staff: The manufacturer must employ a competent person who is a full-time employee, possessing:

1. A degree in pharmacy or science.

2. Or, a diploma in pharmacy/cosmetic technology, along with a specified number of years of experience in cosmetic manufacturing^4,11.

· Equipment: All necessary machinery and apparatus for manufacturing, packaging, and testing the specified classes of cosmetics must be available and maintained in good working order⁵.

· Testing Facilities (In-house or External): Adequate testing facilities must be available, either in the manufacturer’s own laboratory (staffed by a qualified analyst) or through an approved outside testing laboratory⁵.

b] Conditions for Import License:

The import of cosmetics is centrally regulated by the CDSCO under Rule 21.

· Application: The application is submitted via the SUGAM online portal.

· Form: Application must be made in Form 42.

· Requirements: The applicant (importer) must possess adequate space for storage, and the imported product must be manufactured by a licensed company in the country of origin, following that country's good manufacturing practices. A specific Registration Certificate (RC) in Form 43 is issued for the imported product^4,11.

c] Conditions for Sale and Storage License:

A license is required for the wholesale or retail sale and storage of cosmetics, typically granted by the SLA. The premises must meet basic hygiene, storage, and safety standards, ensuring the quality of the product is maintained until it reaches the consumer ¹¹.

3.2. Administrative Authorities in India and Abroad:

Effective compliance necessitates engaging with multiple regulatory bodies domestically and understanding global export requirements.

a] Administrative Authorities in India:

1. Central Drugs Standard Control Organization (CDSCO)

2. State Licensing Authority (SLA)

3. Bureau of Indian Standards (BIS)

b] Administrative Authorities Abroad:

1. USA: Food and Drug Administration (FDA)

2. European Union (EU)

3. ASEAN: ASEAN Cosmetic Directive (ACD)

3.3. Documentation Management Systems:

Documentation is the backbone of CGMP compliance. It provides the legal, historical, and technical evidence that the product was manufactured, tested, and distributed correctly^14,25.

a] Master Formula Record (MFR):

The MFR is the foundational document for a product. It serves as the authoritative blueprint for how a product must be manufactured^23,33.

b] Batch Formula Record (BFR):

The BFR is the actual historical record of a specific batch being manufactured. It is the real-time record filled out during production, demonstrating adherence to the MFR.

c] Quality Audit Report (QAR):

The QAR is a formal document resulting from a systematic, independent examination to determine compliance with planned quality arrangements³⁶.

3.4. Handling Return Goods, Recalling, and Waste Disposal:

These procedures manage products that leave the control of the manufacturer, ensuring safety and environmental responsibility³³.

a] Handling Return Goods:

Returned products must be segregated and quarantined immediately, then evaluated by the Quality Control team. They are classified as salvageable (reworkable), saleable (still meeting specifications), or rejected (for destruction)³³.

b] Product Recalling:

A recall is a mandatory action to retrieve a product from the market due to safety concerns or serious non-compliance. It involves identifying all affected batches, notifying the regulatory authority (CDSCO/SLA) immediately, and retrieving the product.

c] Waste Disposal:

Waste materials must be disposed of in a manner that complies with environmental laws and prevents contamination. Detailed logs of waste type, quantity, and method of destruction must be kept, often requiring documentation from a certified waste disposal agency²¹.

4. Quality, Compliance, and Stability:

Quality assurance is paramount in the cosmeceutical industry, demanding compliance with strict manufacturing standards and rigorous stability testing protocols to guarantee product efficacy and safety throughout its shelf life^14,25.

4.1. Current Good Manufacturing Practices (CGMP) of Cosmetics:

In India, the CGMP requirements for cosmetics are specified in Schedule M-II of the Drugs and Cosmetics Rules, 1945. These practices are mandatory to minimize risks inherent in all production^14,10.

a] The Pillars of cGMP (Schedule M-II):

1. Personnel: All personnel must be qualified, trained, and supervised. They must maintain high standards of personal hygiene.

2. Premises: Facilities must be designed and maintained to facilitate efficient, safe, and clean operation, including proper ventilation and temperature/humidity control^10,24.

3. Equipment: Equipment must be appropriately sized, designed to be easily cleaned and sanitized, and regularly calibrated and maintained.

4. Sanitation and Hygiene: Detailed cleaning procedures (SOPs) are mandatory for premises and equipment. A master cleaning schedule must be maintained.

5. Quality Control System: The overarching system that includes documentation, sampling procedures, specifications, and testing protocols, ensuring that no batch is released until its quality has been fully verified^25,33.

4.2. Study of ICH Guidelines for Stability Studies:

The International Conference on Harmonization (ICH) guidelines provide the universally accepted global standard for stability testing, adopted by the cosmetic industry to determine shelf life and storage conditions ^20,33.

a] ICH Q1 Guidelines (Stability Testing of New Drug Substances and Products):

1. Long-Term Testing: Determines the shelf life. Products are stored at conditions mirroring the intended market conditions.

2. Accelerated Testing: Used to predict chemical degradation quickly. Products are stored at elevated temperatures and humidity. Data from 6 months of accelerated testing can often predict a 2-year shelf life ^5,20,48.

· Parameters Monitored in Stability Studies:

1. Physical: Changes in color, odor, appearance, rheological properties (viscosity/consistency), and phase separation.

2. Chemical: Monitoring the assay of actives (concentration) and the formation of degradation products.

5. Biological Needs and Hygiene:

Understanding the physiology of the human body is foundational to formulating cosmeceuticals that are safe and effective. Product design must be rooted in knowledge of the common problems, structures, and specific needs of various body parts.

5.1. Knowledge about Skin, Oral Cavity, Hair, Nail, and Body Cavity Related Problems:

a] Skin-Related Problems:

1. Acne Vulgaris: Caused by sebum overproduction and follicular clogging. Cosmeceutical Focus: Sebum regulation (Niacinamide), exfoliation (Salicylic Acid, Alpha-Hydroxy Acids), and anti-inflammatory action.

2. Dry Skin (Xerosis): Impaired barrier function and lack of moisture in the stratum corneum.

Cosmeceutical Focus: Supplying emollients, humectants (glycerin), and barrier-repair ingredients (ceramides)^9,47.

3. Hyperpigmentation: Overproduction of melanin. Cosmeceutical Focus: Tyrosinase inhibition (Kojic Acid) and UV protection^17,39.

b] Oral Cavity Related Problems:

1. Dental Caries (Cavities): Demineralization of enamel due to acid. Cosmeceutical Focus: Re-mineralization via Fluoride (Sodium Monofluorophosphate).

2. Gingivitis and Periodontitis: Gum inflammation caused by plaque. Cosmeceutical Focus: Anti-plaque agents and anti-inflammatory ingredients.

3. Halitosis (Bad Breath): Caused by volatile sulfur compounds produced by anaerobic bacteria. Cosmeceutical Focus: Antibacterial agents and ingredients that neutralize (zinc salts)^35,46.

c] Hair and Scalp Problems:

1. Dandruff: Flaking linked to the yeast Malassezia globosa. Cosmeceutical Focus: Antifungal agents (zinc pyrithione, selenium sulfide) in medicated shampoos.

2. Hair Damage: Breakdown of the hair's protective cuticle layer. Cosmeceutical Focus: Conditioning polymers and proteins (hydrolyzed wheat protein) that repair the cuticle^5,12,44.

d] Nail and Body Cavity Problems:

1. Nails: Require products (cuticle oils, nail hardeners) to maintain hydration and flexibility.

2. Body Cavities: Products for these areas must be formulated with extreme care, ensuring appropriate (slightly acidic for the vaginal area) and non-irritating, hypoallergenic ingredients^35,45.

6. Ethnic Formulation Considerations:

Effective cosmeceutical development must account for the diverse anatomical, climatic, and cultural needs of various global populations.

6.1. Detailed Formulation Consideration for Key Product Categories:

a] Moisturizing Cream:

· Thicker Bases (Colder/Drier Climates): Use higher concentrations of occlusive agents like petrolatum or mineral oil.

· Lighter Bases (Humid/Tropical Climates): Use lighter emollients like Capric Triglyceride and focus on water-based humectants (Glycerin) to prevent a heavy, greasy feel on oil-prone skin^5,29.

Fig 1: Moisturizing Cream ⁵

b] Vanishing Cream:

· Definition: An oil-in-water emulsion containing a high percentage of stearic acid (15%-20%). It "vanishes" upon rubbing due to water evaporation and leaves a non-greasy, matte finish, suitable for oily skin types.

· Key Ingredients: Stearic Acid, Potassium Hydroxide or Triethanolamine (to saponify the acid), Water, and Humectants ^22,50.

Fig. 2: Vanishing Cream ²²

c] Cold Cream:

· Definition: A water-in-oil emulsion. The external oil phase gives it its rich, occlusive, and heavy feel. The "cold" sensation comes from the slow evaporation of water trapped inside the oil phase.

· Function: Excellent for cleansing (dissolves makeup and dirt) and providing intense overnight moisturization for very dry skin types ^5,29.

Fig.3: Cold Cream ²⁹

c] Shaving Creams:

· Key Ingredients (Lather Type): A blend of a soft soap (potassium hydroxide) and a hard soap (sodium hydroxide) to provide both quick and stable lather. Glycerin and sorbitol keep the stubble soft ²⁹.

Fig.4: Shaving Creams ²⁹

d] Dentifrices (Toothpaste):

· Key Ingredients (Detailed):

1. Abrasive: Hydrated Silica or Calcium Carbonate (20-50%).

2. Humectant: Glycerin or Sorbitol (20-35%) to prevent drying out.

3. Binder: Carboxymethylcellulose or Xanthan Gum.

4. Therapeutic Agent: Fluoride source (as ion) ^[5,35].

Fig.5: Dentifrices (Toothpaste) ^5,35

e] Perfumes and Prickly Heat Powder:

· Perfumes: Composed of denatured ethyl alcohol (carrier) and perfume oil (fragrance complex) ³⁷.

Fig. 6: Perfumes ³⁷.

· Prickly Heat Powder: Used to absorb moisture in hot, humid climates.

Key Ingredients: Talc (or starch) as the bulk adsorbent, Boric Acid (or antimicrobials), Menthol (for cooling), and Zinc Oxide (for soothing) ²⁹.

Fig. 7: Prickly Heat Powder ²⁹

f] Aerosols, Lotions, and Solid Dosage Forms.

· Aerosols: Require a propellant (e.g., hydrocarbons) and an active formulation ³⁷.

Fig. 8: Aerosols ³⁷

7. Manufacturing and Quality Control Operations:

This module focuses on the operational excellence required on the factory floor, covering process standardization, required equipment, and practical quality evaluation.

7.1. Preparation of SOPs of Different Equipment and Machineries:

SOPs are mandatory under CGMP (Schedule M-II). They ensure that every task is performed consistently, regardless of the operator ^10,24.

A] Essential Categories of SOPs:

1. Equipment Operation SOPs

2. Cleaning and Sanitation SOPs

3. Quality Control SOPs

4. Material Handling SOPs

7.2. Manufacturing and Quality Control Equipment:

Modern cosmeceutical manufacturing utilizes high-precision equipment to achieve uniform product quality and high throughput.

B] Hands-on Quality Control Instruments (Function and visual representation):

A] Texture Analyzer:

A texture analyzer is a sophisticated instrument that measures the mechanical and physical properties of a material, primarily food, pharmaceuticals, and cosmetics, by simulating user interaction. It works by physically deforming a sample in a controlled manner (e.g., compression, tension, shear, puncture) and measuring the force response over time. This data is converted into numerical values that correlate to sensory attributes like firmness, crunchiness, stickiness, and springiness^16,51.

Fig. 9: Texture Analyzer ¹⁶

B] Brookfield Viscometer:

A Brookfield viscometer is a type of rotational viscometer used to measure the viscosity (resistance to flow) of a fluid. It operates by rotating a spindle (rotor) submerged in the test fluid at a controlled speed and measuring the torque required to overcome the viscous resistance. The torque is then converted into a viscosity value, often expressed in centipoise or Pascal-seconds ³⁰.

Fig. 10: Brookfield Viscometer ³⁰

C] Colony Counter:

A colony counter is an instrument used in microbiology to count the number of microbial colonies (bacteria or fungi) growing on a culture plate (like an agar plate). This count is essential for calculating the concentration of microorganisms in a sample (colony-forming units per milliliter, or CFU/ml). Automated versions use sophisticated optics and software, while manual versions use a magnifying lens and a pressure-sensitive tallying mechanism ²⁷.

Fig.11: Colony Counter ²⁷

8. CONCLUSION:

The success of the modern cosmeceuticals industry relies on a seamless integration of scientific formulation, rigorous quality systems (CGMP and ICH), and meticulous adherence to the regulatory mandates set forth by the D&C Act, 1940. By establishing robust SOPs, maintaining accurate documentation (MFR/BFR), and utilizing high-precision manufacturing and QC instrumentation, companies can not only ensure product safety and efficacy but also build consumer trust in a highly competitive global market. The future of this industry is tied directly to its commitment to these detailed standards.

This thorough study demonstrates that maintaining market leadership in the cosmeceutical industry requires a strong dedication to quality, inherent integrity, and verified customer assurance, which goes beyond simple product innovation. The Drug and Cosmetics Act, 1940, which outlines India's regulatory structure, makes strict adherence the unavoidable cornerstone of any business. This is appropriately understood as a serious agreement with the public rather than as a burdensome procedure. This commitment is kept, and priceless confidence is fostered via the effective acquisition of required authorizations and the careful maintenance of perfect Master Formula Records (MFRs) and Batch Formula Records (BFRs) in accordance with Current Good Manufacturing Practices (CGMP).

The study unequivocally affirms that careful, methodical Quality Assurance (QA) and Quality Control (QC) processes ensure product reliability. Businesses are actively reducing risk when they incorporate international standards such as the ICH Stability Guidelines, ensuring that the product is safe and proven effective for the duration of its commercial existence. Furthermore, excellent formulation necessitates true insight and foresight—a thorough comprehension of the distinct physiological needs of various populations, allowing for the custom customization of care plans for each particular anatomical area.

9. REFERENCES:

1. Aghili, A., Jaimand, K., and Mohebali, A. (2018). Handbook of Cosmeceutical Science and Technology. CRC Press.

2. Bajaj, S., and Saini, V. (2016). Regulatory Aspects of Cosmetics. Elsevier India.

3. Banker, G. S., and Rhodes, C. T. (Eds.). (2018). Modern Pharmaceutics (5th ed.). Marcel Dekker, Inc.

4. Bharucha, K. E. (2019). Drug and Cosmetics Act, 1940, and Rules, 1945. Commercial Law Publishers.

5. Bhushan, M., and Singh, A. K. (2017). Cosmetic Formulation and Quality Control. S. Chand and Company.

6. Bodeker, G. (Ed.). (2019). The Business of Traditional Medicine. Churchill Livingstone.

7. CDSCO. (2020). Guidelines for Import and Registration of Cosmetics in India. Central Drugs Standard Control Organisation.

8. Cosmetic Ingredient Review (CIR). (2021). Review of Cosmetic Ingredients. CIR Expert Panel.

9. Draelos, Z. D. (2018). Cosmeceuticals: Efficacy, Safety, and Regulation (3rd ed.). CRC Press.

10. Eadie, R. (2019). Good Manufacturing Practices for Pharmaceuticals (7th ed.). Informa Healthcare.

11. Estapé, T. P., and Otero, J. A. P. (2021). Cosmetic Regulation in the European Union and the United States. Springer.

12. Faergemann, J., and Baran, R. (2018). Handbook of Cosmetic Science and Technology (4th ed.). Blackwell Publishing.

13. Food and Drug Administration (FDA). (2022). Cosmetics: Labeling Requirements. U.S. FDA.

14. Ghadam, M., and Shinde, V. (2015). Pharmaceutical Quality Assurance. Nirali Prakashan.

15. Gopinath, V. K., and Lall, S. B. (2020). Biotechnology of Cosmetics and Cosmeceuticals. Nova Science Publishers.

16. Grove, G. L., and Kalia, Y. N. (2017). Biophysical Techniques in Drug Discovery and Development. Royal Society of Chemistry.

17. Gupta, A. K., and Kogan, N. (2016). Cosmeceuticals and Active Cosmetics. Taylor and Francis Group.

18. Hadgraft, J., and Lane, M. E. (2019). Absorption and Distribution of Drugs and Cosmetics. Pharmaceutical Press.

19. Harborne, J. B., and Baxter, H. (2018). Dictionary of Plant Toxins and Natural Product Chemistry. CRC Press.

20. ICH. (2016). Q1A(R2): Stability Testing of New Drug Substances and Products. International Conference on Harmonisation.

21. Jain, A., and Jain, S. K. (2018). Pharmaceutical Industrial Management. CBS Publishers.

22. Jain, S. K. (2017). Cosmetic Science: Formulations and Quality Control. Vallabh Prakashan.

23. Kanazawa, A. (2018). Advances in Drying Technologies (Vol. 5). CRC Press.

24. Kapoor, R., and Singh, V. (2019). Fundamentals of Good Manufacturing Practices. Pharma Book Syndicate.

25. Khetarpal, S., and Bhasin, G. (2017). Pharmaceutical Quality Management. University Science Press.

26. Kydonieus, A. (2018). Fundamentals of Controlled Release Systems. Springer.

27. Lee, J., and Smith, K. (2020). Microbiological Testing in the Cosmetic Industry. Elsevier.

28. Lewi, S. P. (2017). Understanding and Implementing the European Union Cosmetic Regulation. Cosmetic Compliance Ltd.

29. Mahato, R. I., and Narang, A. S. (2018). Pharmaceutical Suspensions and Emulsions. Springer.

30. Masuda, S., and Sato, T. (2019). Rheology of Complex Fluids. Springer.

31. Ministry of Health and Family Welfare (India). (1940). The Drugs and Cosmetics Act, 1940. Government of India.

32. Mittal, K. L. (2017). Cosmetic and Toiletries: Chemistry, Manufacturing and Use. CRC Press.

33. Murthy, S. N. (2019). Pharmaceutical Product Development and GMP. Springer.

34. Nanda, S., and Sharma, M. (2021). Cosmeceuticals and the Skin: A Review of Efficacy. Wiley-Blackwell.

35. Pathak, D. P., and Nanda, S. (2016). Biochemistry of Oral Health. CBS Publishers.

36. Rajagopal, S. (2018). Quality Management Systems in Pharmaceutical Industry. Jaypee Brothers Medical Publishers.

37. Schmaus, G., and Wenck, H. (2018). Aerosol Technology for Cosmetic and Personal Care. Springer.

38. Singh, S., and Bakliwal, M. (2020). Pharmaceutical Dosage Forms: Tablets and Capsules. Narosa Publishing House.

39. Smith, E. W., and Maibach, H. I. (2019). Handbook of Non-Invasive Methods and the Skin (3rd ed.). CRC Press.

40. Williams, R. L. (2018). Cosmetic Science and Technology: A Guide for the Non-Chemist. Allured Publishing Corp.

41. Ashwini M. Chaudhari, Rupali V. Khankari, Payal J. Chavan. Review on Study of Cosmeceuticals. Research Journal of Topical and Cosmetic Sciences. 2023; 14(2): 79-4. doi: 10.52711/2321-5844.2023.00012

42. Pooja Khanpara, Nima Sojitra. Formulation and Evaluation of Anti-aging Purple Herbal Gel Cream. Research Journal of Topical and Cosmetic Sciences. 2023; 14(2):58-4. doi: 10.52711/2321-5844.2023.00009.

43. Chetan J. Girase, Nilesh K. Nerkar, Revati S. Patil, Darshana M. Borse, Paresh A Patil. Formulation and Characterization of Aloe-Vera gel and Orange Peel Powder containing Cream. Research Journal of Topical and Cosmetic Sciences. 2023; 14(2): 65-2. doi: 10.52711/2321-5844.2023.00010.

44. Siddhi Pise, Fareed Shaikh, Payaam Vohra.Formulation and Evaluation of Herbal Anti-acne Face Scrub. Research Journal of Topical and Cosmetic Sciences. 2023; 14(2): 53-7. doi: 10.52711/2321-5844.2023.00008.

45. Karuna. J. Choudhary, Hasni. Sayyed. Hamid, S. P Pawar. Review on Herbal Hair Serum. Research Journal of Topical and Cosmetic Sciences. 2025; 16(2):117-3. doi: 10.52711/2321-5844.2025.00019.

46. Pratik Terse, Shraddha Mane, Tanuja Patil, Sakshi Ruke, Gauri Mane. Natural Protection: The Benefits of Herbal Lip Balm for Healthier Lips. Research Journal of Topical and Cosmetic Sciences. 2025; 16(2): 111-6. doi: 10.52711/2321-5844.2025.00018.

47. Padmini Hrudeshnandan Sharma, Aman Sharma, Prathmesh Chopade, Harshali Kale, Nikhil Bhujbal. Preparation and Evaluation of Herbal Moisturizer Gloves for the Treatment of Dry Hand. Research Journal of Topical and Cosmetic Sciences. 2025; 16(2): 97-1. doi: 10.52711/2321-5844.2025.00016.

48. Shital P Khavare, Sakshi D Danawade, Vrushali G Khot. Formulation and Evaluation of Ketoconazole Gel for Topical Use. Research Journal of Topical and Cosmetic Sciences. 2025; 16(2): 91-6. doi: 10.52711/2321-5844.2025.00015.

49. Harshal Patil, Jyotsna Waghmare. Formulation and Characterization of Natural Foaming Face Wash Utilizing Hazelnut Oil Microemulsion for Enhanced Skin Nourishment and Stability. Research Journal of Topical and Cosmetic Sciences. 2025; 16(2): 86-0. doi: 10.52711/2321-5844.2025.00014.

50. Prajakta. S. Chavan, Aneri. V. Adsul, Resham. N. Ingawale, Vaishnavi. S. Salunkhe. Natural Hair Dye: A Overview. Research Journal of Topical and Cosmetic Sciences. 2025; 16(2): 149-6. doi: 10.52711/2321-5844.2025.00023.

51. Rohini C. Kolhe, Aarti Shivareddy. Exploring Cannabidiol’s Therapeutic Potential in Skincare with Focus on Anti-Inflammation and Antioxidant Activity. Research Journal of Topical and Cosmetic Sciences. 2025; 16(2): 142-8. doi: 10.52711/2321-5844.2025.0002

Received on 22.12.2025 Revised on 15.01.2026

Accepted on 07.02.2026 Published on 18.04.2026

Available online from April 25, 2026

Research J. Topical and Cosmetic Sci. 2026; 17(1):69-76.

DOI: 10.52711/2321-5844.2026.00012

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.